1st National Neurogenetic Variant Interpretation Course (Virtual Course)
Who should attend The review course is aimed at practicing neurologists, neurology residents and fellows across Canada who are interested in a comprehensive review of the current clinical genetic practices dealing with neurological diseases, as well as genetic counsellors interested in learning more about neurogenetic testing and pathogenic, benign, and variants of uncertain significance (VUS) interpretation.
Benefits of attending This comprehensive review course will assist in bringing neurology specialists up to date on the role of genetics in neurological diseases so they can improve the clinical care of their patients. This course may also serve to inform diagnosis, clinical management, and clinical trial eligibility.
Learning Objectives
1. Understand the role of genetic counsellors in neurology.
2. Recognize when an underlying genetic cause should be considered.
3. Become familiar with the process of gene panel selection and lab report interpretation.
4. Review ACMG criteria for variant classification and VUS interpretation.
5. Introduction to frequently used variant interpretation resources.
Co-organizers
Sali Farhan, PhD (Assistant Professor and Clinical Molecular Geneticist)
Allison Dilliott, PhD (Post-Doctoral Scholar)
Kayla Horowitz (Genetic counsellor), The Neuro
Alana Mistry (Genetic counsellor), The Neuro
Nellie Fotopoulos, PhD (Genetic counsellor), The Neuro
Contact: sali.farhan [at] mcgill.ca (Sali Farhan), Assistant Professor, Dept. of Neurology and Neurosurgery, and Human Genetics, The Neuro